Clinical Trial Update: IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating IX001 TCR-T therapy for advanced pancreatic cancer and KRAS-mutant colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• IX001 TCR-T

Snippet

Sponsor: Shanghai Pudong Hospital | Conditions: Pancreatic Cancer, Colorectal Cancer | Phase 1 | Status: RECRUITING